celecoxib has been researched along with Rheumatic Diseases in 11 studies
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib significantly increased the incidence of new onset hypertension in this cohort of Indian patients with rheumatic diseases." | 7.79 | How safe is Celecoxib for Asian-Indian patients with rheumatic diseases? ( Chandra, C; Chandy, SJ; Danda, D; Iliyas, MM; Mathew, AJ, 2013) |
| "The Authors summarize the current knowledge on a new class of nonsteroidal anti-inflammatory drugs (NSAIDs), the coxib (celecoxib and rofecoxib), in the treatment of rheumatic diseases." | 4.81 | [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives]. ( Nervetti, A; Rioda, WT, 2001) |
| "Celecoxib significantly increased the incidence of new onset hypertension in this cohort of Indian patients with rheumatic diseases." | 3.79 | How safe is Celecoxib for Asian-Indian patients with rheumatic diseases? ( Chandra, C; Chandy, SJ; Danda, D; Iliyas, MM; Mathew, AJ, 2013) |
| "To simultaneously assess the short-term reduction in risk of gastrointestinal (GI) complications and increase in risk of acute myocardial infarction (MI) by celecoxib compared with rofecoxib and several nonselective nonsteroidal antiinflammatory drugs (NSAIDs) using instrumental variable analysis." | 3.73 | Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. ( Brookhart, MA; Rassen, J; Schneeweiss, S; Solomon, DH; Wang, PS, 2006) |
| "We tested whether this parameter and tactile allodynia, the standard pain measure in preclinical studies, show parallels in their response to analgesics and basic mechanisms." | 1.46 | Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia. ( Cañizares, FJ; Cobos, EJ; Entrena, JM; Fernández-Segura, E; Montilla-García, Á; Perazzoli, G; Portillo-Salido, E; Tejada, MÁ, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montilla-García, Á | 1 |
| Tejada, MÁ | 1 |
| Perazzoli, G | 1 |
| Entrena, JM | 1 |
| Portillo-Salido, E | 1 |
| Fernández-Segura, E | 1 |
| Cañizares, FJ | 1 |
| Cobos, EJ | 1 |
| Danda, D | 1 |
| Iliyas, MM | 1 |
| Chandy, SJ | 1 |
| Chandra, C | 1 |
| Mathew, AJ | 1 |
| Babić-Naglić, D | 1 |
| Gibofsky, A | 1 |
| Tsurko, VV | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Ob ukhova, OA | 1 |
| Krüger, K | 1 |
| Schneeweiss, S | 1 |
| Solomon, DH | 1 |
| Wang, PS | 1 |
| Rassen, J | 1 |
| Brookhart, MA | 1 |
| Sperling, R | 1 |
| Braunstein, N | 1 |
| Melin, J | 1 |
| Reicin, A | 1 |
| Gotlieb, D | 1 |
| Rioda, WT | 1 |
| Nervetti, A | 1 |
4 reviews available for celecoxib and Rheumatic Diseases
| Article | Year |
|---|---|
Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase Inhibitors; Humans; La | 2002 |
[Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheuma | 2003 |
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, | 2005 |
[Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Cyclooxygenase 2; Cyclooxygena | 2001 |
7 other studies available for celecoxib and Rheumatic Diseases
| Article | Year |
|---|---|
Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia.
Topics: Acetaminophen; Analgesics; Animals; Arthritis; Celecoxib; Disease Models, Animal; Diterpenes; Female | 2017 |
How safe is Celecoxib for Asian-Indian patients with rheumatic diseases?
Topics: Adult; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Drug Substitution; Female; Humans; Hyperten | 2013 |
Robin goodfellow.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Celecoxib; Clinical Trials as Topic; Humans; Inflixima | 2002 |
[Celecoxib].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Pyrazoles; Rheumatic Diseases; Sulfonami | 2001 |
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; F | 2006 |
Cyclooxygenase 2 inhibitors and thrombogenicity production: comment on the article by Crofford et al.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzy | 2001 |
Celecoxib-- the debate ranges on.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Humans; Insurance Cover | 2001 |